The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of using fitness tracker to assess activity level and toxicities in colorectal cancer (CRC) patients (Pts).
 
Thomas Holden
No Relationships to Disclose
 
Maureen Hill
No Relationships to Disclose
 
William Harrell Ward
No Relationships to Disclose
 
Caitlin R. Meeker
No Relationships to Disclose
 
Elizabeth A. Handorf
Research Funding - Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
 
Michael J. Hall
Research Funding - Ambry Genetics; Ambry Genetics; Ambry Genetics; Ambry Genetics; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; InVitae; InVitae; InVitae; InVitae; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics
Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst); I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst); I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst); I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics
Other Relationship - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Invitae; Invitae; Invitae; Invitae; Myriad Genetics; Myriad Genetics; Myriad Genetics; Myriad Genetics
 
Elin R. Sigurdson
No Relationships to Disclose
 
Igor A. Astsaturov
Honoraria - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences
Consulting or Advisory Role - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Guardant Health; Guardant Health; Guardant Health; Guardant Health
Speakers' Bureau - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences
 
Crystal S. Denlinger
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; BeiGene; BeiGene; BeiGene; BeiGene; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck
Research Funding - Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lycera (Inst); Lycera (Inst); Lycera (Inst); Lycera (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Zymeworks (Inst); Zymeworks (Inst); Zymeworks (Inst); Zymeworks (Inst)
 
Sanjay S. Reddy
No Relationships to Disclose
 
Joshua E. Meyer
Honoraria - Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems
Research Funding - Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems
Travel, Accommodations, Expenses - Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems; Varian Medical Systems
 
Matthew R. Zibelman
Honoraria - Pfizer; Pfizer; Pfizer; Pfizer
Consulting or Advisory Role - EMD Serono; EMD Serono; EMD Serono; EMD Serono; Horizon Pharma; Horizon Pharma; Horizon Pharma; Horizon Pharma; Janssen; Janssen; Janssen; Janssen; Pfizer; Pfizer; Pfizer; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Horizon Pharma (Inst); Horizon Pharma (Inst); Horizon Pharma (Inst); Horizon Pharma (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
Other Relationship - Association of Community Cancer Centers (ACCC); Association of Community Cancer Centers (ACCC); Association of Community Cancer Centers (ACCC); Association of Community Cancer Centers (ACCC)
 
Efrat Dotan
Honoraria - Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical; Pfizer; Pfizer; Pfizer; Pfizer
Consulting or Advisory Role - ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
 
Jeffrey M. Farma
Other Relationship - Delcath Systems; Delcath Systems; Delcath Systems; Delcath Systems
 
Namrata Vijayvergia
Research Funding - Bayer; Bayer; Bayer; Bayer; Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst)